BISTTRY12:21Live
Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş.GENIL
Star MarketChemicals, Petroleum, Rubber and Plastics
6.78−0.57 (−7.76%)
- Volume
- TRY 153.8M
- Day range
- 6.64 – 7.18
- Previous close
- 7.35
- Market cap
- TRY 30.5B
GENIL Ratio Analysis: P/E, P/B, EV/EBITDA
35 key ratios for Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (GENIL) computed from the latest financial statements and the current price: valuation, profitability, liquidity, leverage and efficiency.
Ratio Analysis
| P/E | 24.02 |
| P/B | 2.39 |
| EV/EBITDA | 12.34 |
| Dividend yield | 0.17% |
| Beta | — |
| Earnings per share | 0.3 TL |
| Book value per share | 2.9 TL |
| EBITDA | 2.1B TL |
| Net profit | 891.8M TL |
| Operating profit | 2B TL |
| Operating profit before finance costs | 1.9B TL |
| Net working capital | 2.7B TL |
| Gross margin | 25.43% |
| Operating margin | 14.59% |
| Net margin | 6.34% |
| Return on assets | 6.36% |
| Return on equity | 11.39% |
| Current ratio | 1.29 |
| Quick ratio | 1.05 |
| Cash ratio | — |
| Leverage ratio | 44.64 |
| Debt to equity | 0.81 |
| Debt to assets | 0.45 |
| Fixed assets to equity | 0.89 |
| Short-term debt share | 0.45 |
| Interest coverage | — |
| Receivables turnover | 0.75 |
| Days sales outstanding | 487 |
| Inventory turnover | 4.70 |
| Days inventory outstanding | 78 |
| Payables turnover | 3.27 |
| Days payables outstanding | 112 |
| Working capital turnover | 5.22 |
| Equity turnover | 1.08 |
| Asset turnover | 0.60 |
Frequently asked questions
What is the P/E ratio of GENIL?
GENIL has a P/E ratio of 24.02, a P/B ratio of 2.39 and an EV/EBITDA of 12.34.
When are the ratios updated?
Price-based ratios (P/E, P/B, EV/EBITDA, dividend yield) refresh daily; balance-sheet ratios refresh after the company publishes its KAP financial report.